Back
Biogen, Inc. Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
64
BIIB
Biogen, Inc.
Last Price:
$186.94
Seasonality Move:
-0.76%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atBiogen, Inc. Stock Forecast
-
Over the next 52 weeks, Biogen, Inc. has on average historically risen by 40.2% based on the past 34 years of stock performance.
-
Biogen, Inc. has risen higher in 22 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%
-
Is Biogen, Inc. Stock Undervalued?The current Biogen, Inc. [BIIB] share price is $186.00. The Score for BIIB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
BIIB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Biogen, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Biogen, Inc. has on average historically risen by 40.2% based on the past 34 years of stock performance.
Biogen, Inc. Stock Rating
Buy
64
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. overpriced?
-
Biogen, Inc. has risen higher in 22 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%
Biogen, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
187.77
52-Week Low:
110.04
Prediction Charts
Market Cap:
27.3B
Price in USD:
186.00
Volume:
1.6M
Beta:
0.86
Technical Analysis
SMA50:
170.08
SMA100:
156.62
SMA200:
142.01
52-Wk Change:
23.38%
Stock Predictions
-
Is Biogen, Inc. stock public?Yes, Biogen, Inc. is a publicly traded company.
-
What is the Biogen, Inc. stock quote today?The Biogen, Inc. stock price is 186.00 USD today.
-
How to buy Biogen, Inc. stock online?You can buy Biogen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 171.43 | 172.10 | 173.83 | 169.55 |
| Dec-18 | 171.59 | 169.91 | 173.00 | 168.56 |
| Dec-19 | 171.32 | 174.80 | 176.42 | 170.00 |
| Dec-22 | 174.78 | 174.70 | 177.29 | 172.90 |
| Dec-23 | 174.26 | 174.82 | 175.58 | 173.08 |
| Dec-24 | 175.73 | 176.33 | 177.18 | 175.37 |
| Dec-26 | 175.30 | 177.08 | 177.19 | 175.00 |
| Dec-29 | 177.00 | 176.83 | 178.46 | 176.31 |
| Dec-30 | 176.30 | 176.40 | 176.99 | 175.72 |
| Dec-31 | 175.76 | 175.99 | 177.19 | 175.02 |
| Jan-5 | 175.73 | 174.63 | 180.56 | 171.61 |
| Jan-6 | 174.94 | 182.61 | 182.97 | 174.30 |
| Jan-7 | 181.70 | 186.91 | 187.06 | 181.70 |
| Jan-8 | 187.02 | 186.00 | 187.77 | 183.50 |
Biogen, Inc. Earnings
Biogen, Inc. Earnings Report: Per Share Biogen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen, Inc. Forecast Revenue Growth
Biogen, Inc. Stock Analysis: Historical quarterly revenues per share for Biogen, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.80 per share.
* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.